Ardsley Advisory Partners LP Lowers Stock Holdings in Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Ardsley Advisory Partners LP trimmed its position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 32.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,064,614 shares of the company's stock after selling 514,774 shares during the quarter. Ardsley Advisory Partners LP owned about 1.70% of Bioceres Crop Solutions worth $6,473,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of BIOX. JPMorgan Chase & Co. raised its holdings in shares of Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock worth $708,000 after purchasing an additional 29,693 shares during the last quarter. Ballast Asset Management LP lifted its holdings in shares of Bioceres Crop Solutions by 23.5% in the 4th quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock valued at $2,620,000 after buying an additional 82,187 shares during the period. Fourth Sail Capital LP boosted its stake in shares of Bioceres Crop Solutions by 16.6% in the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company's stock worth $22,490,000 after buying an additional 527,859 shares during the last quarter. Jump Financial LLC purchased a new stake in shares of Bioceres Crop Solutions in the fourth quarter worth about $72,000. Finally, Long Focus Capital Management LLC raised its position in Bioceres Crop Solutions by 130.7% during the fourth quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company's stock valued at $4,528,000 after acquiring an additional 421,931 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company's stock.

Bioceres Crop Solutions Trading Up 6.8 %

Shares of BIOX stock traded up $0.28 on Thursday, hitting $4.39. 71,032 shares of the stock traded hands, compared to its average volume of 169,724. Bioceres Crop Solutions Corp. has a twelve month low of $3.51 and a twelve month high of $13.18. The stock has a market capitalization of $275.30 million, a PE ratio of 219.61 and a beta of 0.40. The firm's 50-day moving average price is $4.36 and its two-hundred day moving average price is $5.67. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.96 and a current ratio of 1.33.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Oppenheimer decreased their target price on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating for the company in a research note on Tuesday, April 22nd. Canaccord Genuity Group lowered their price target on Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Finally, Lake Street Capital reduced their target price on Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating for the company in a research note on Friday, February 7th. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Buy" and an average price target of $8.63.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.